Chronic Disease Rise Fuels Albumin Excipient Market Growth: The Driving Engine Behind Albumin Excipient Market Evolution in 2025

Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.

Albumin Excipient Market Size Growth Forecast: What to Expect by 2025?
The size of the albumin excipient market has been witnessing significant growth in recent years. It is estimated to rise from $4.85 billion in 2024 to $5.15 billion in 2025 with a Compound Annual Growth Rate (CAGR) of 6.1%. Factors such as the expansion of the biopharmaceutical industry, a heightened adoption of biologics, an increased occurrence of chronic diseases, advancements in clinical procedures and drug innovation as well as an intensified focus on drug delivery have contributed to this growth in the historical period.

How Will the Albumin Excipient Market Size Evolve and Grow by 2029?
Predictions suggest a robust expansion in the albumin excipient market in the coming years, reaching $6.64 billion in 2029 with a compound annual growth rate (CAGR) of 6.6%. Factors contributing to this projected growth during the forecast period encompass an ongoing expansion in biopharmaceuticals, increased investments in drug development, a higher count of older adults, global efforts toward vaccinations, and a burgeoning biologics pipeline. Noteworthy trends during this period include application in cell therapy, customized and tailored solutions, regulatory adherence and quality standards, collaborations and partnerships focused on research, along with bio-degradable and bio-compatible properties.

View the full report here:
https://www.thebusinessresearchcompany.com/report/albumin-excipient-global-market-report

What Drivers Are Propelling the Growth of Albumin Excipient Market Forward?
The escalating occurrence of long-term health conditions is forecasted to bolster the albumin excipient market's expansion. Chronic diseases are ailments that persist for at least three months and can worsen over time. Albumin, the most plentiful circulating protein in plasma, is utilized as a blood volumizer. It also serves as a versatile protein carrier for drug targeting and enhances the pharmacokinetic profile of peptide or protein-based drugs and is utilized in the treatment of various illnesses such as cancer and diabetes. As an example, in February 2024, the World Health Organization, a Switzerland-based United Nations agency, predicted over 35 million new cancer cases by 2050, a surge of 77% compared to the anticipated 20 million cases in 2022. Consequently, the increasing occurrence of chronic diseases is fueling the growth of the albumin excipient market.

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=10672&type=smp

Which Fast-Growing Trends Are Poised to Disrupt the Albumin Excipient Market?
Leading firms in the albumin excipient market are embracing a strategic partnership strategy to cater to crucial biotechnology and pharmaceutical sectors. Such partnerships entail a process where companies utilise each other's competencies and resources for shared benefits and triumph. For example, ARTES Biotechnology GmbH, a biotechnology firm based in Germany, formed a partnership with Basic Pharma, a pharmaceutical company based in the Netherlands, in October 2023. Their aim is to bolster pharmaceutical recombinant protein production by optimising the supply chain and reducing the time-to-market for newly developed products.

What Are the Key Segments in the Albumin Excipient Market?
The albumin excipient market covered in this report is segmented -

1) By Product: Human Serum Albumin, Recombinant Albumin
2) By End-Users: Pharmaceutical And Biotechnology Industry, Research Institutes, Other End Users

Subsegments:
1) By Human Serum Albumin: 5% Human Serum Albumin, 20% Human Serum Albumin
2) By Recombinant Albumin: Recombinant Human Serum Albumin, Recombinant Bovine Serum Albumin

Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=10672&type=smp

Who Are the Key Players Shaping the Albumin Excipient Market's Competitive Landscape?
Major companies operating in the albumin excipient market include Albumin Therapeutics LLC, Biotest AG, CSL Behring,Grifols S.A., HiMedia Laboratories LLC, InVitria Inc., Medxbio Pte Ltd., Octapharma AG, RayBiotech Inc., SeraCare Life Sciences Inc., Sigma-Aldrich Pty. Ltd., Hualan Biological Engineering Inc., Kedrion Biopharma, LFB USA Inc., Shanghai RAAS Blood Products Co. Ltd., Baxter International Inc., Merck KGaA, Thermo Fisher Scientific Inc., Albumedix A/S, Bio Products Laboratory Ltd., Shire Plc., Ventria Bioscience Inc., Novartis AG, China Biologic Products Holdings Inc., ProMetic Life Sciences Inc., Sanquin, Biopharma, Takeda Pharmaceutical Company Limited, FUJIFILM Irvine Scientific Inc.

What Geographic Markets Are Powering Growth in the Albumin Excipient Market?
North America was the largest region in the Albumin Excipient market in 2024.Asia-Pacific is expected to be the fastest-growing region in the global albumin excipient market report during the forecast period. The regions covered in the albumin excipient market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=10672

This Report Supports:
1.Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2.Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3.Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4.Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Saumya Sahey
Europe: +44 7882 955267,
Asia: +44 7882 955267 & +91 8897263534,
Americas: +1 310-496-7795
Email: saumyas@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.